Literature DB >> 15653171

Oxidative stress related markers in the "VITA" and the centenarian projects.

E Grünblatt1, R Schlösser, P Fischer, M O Fischer, J Li, E Koutsilieri, I Wichart, N Sterba, D Rujescu, H J Möller, W Adamcyk, B Dittrich, F Müller, K Oberegger, G Gatterer, K J Jellinger, N Mostafaie, S Jungwirth, K Huber, K H Tragl, W Danielczyk, P Riederer.   

Abstract

Oxidative stress seems to play an important role in the pathophysiology of Alzheimer's disease (AD). At present there are no easily accessible biochemical markers for AD. We performed activity assays for platelet MAO-B and erythrocyte Cu/Zn-SOD as well as Western blotting for these two proteins. Moreover, we assessed plasma lactoferrin and performed RFLP-analysis for the MAO-B-intron-13-polymorphism in patients from the Vienna-Transdanube Aging (VITA) and from the so called centenarian project. The first one, VITA, is a community-based cohort study of all 75 years old inhabitants of a geographical region of Vienna. The centenarian project investigates chronic care in-old patients suffering from AD. In both sexes platelet MAO-B activity increased significantly in the AD group, and Cu/Zn-SOD activity decreased, but the latter effect was significant only in females. No significant difference was found regarding plasma lactoferrin. No correlation was found between MAO-Bi13 and MAO-B platelet activity or allele MAO-Bi13 and disease frequency. These results point to the possibility that a combination of MAO-B and SOD activity levels might be useful tools for an early diagnosis of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653171     DOI: 10.1016/j.neurobiolaging.2004.06.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

2.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

Review 3.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

4.  Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.

Authors:  Jasmin Bartl; Andrea Meyer; Svenja Brendler; Peter Riederer; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

5.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

6.  Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.

Authors:  Viola Vaccarino; Marie-Luise Brennan; Andrew H Miller; J Douglas Bremner; James C Ritchie; Frauke Lindau; Emir Veledar; Shaoyong Su; Nancy V Murrah; Linda Jones; Farhan Jawed; Jun Dai; Jack Goldberg; Stanley L Hazen
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

7.  Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.

Authors:  Claus-Jürgen Scholz; Heike Weber; Susanne Jungwirth; Walter Danielczyk; Andreas Reif; Karl-Heinz Tragl; Peter Fischer; Peter Riederer; Jürgen Deckert; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

8.  Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.

Authors:  Jasmin Bartl; Claus-Jürgen Scholz; Margareta Hinterberger; Susanne Jungwirth; Ildiko Wichart; Michael K Rainer; Susanne Kneitz; Walter Danielczyk; Karl H Tragl; Peter Fischer; Peter Riederer; Edna Grünblatt
Journal:  BMC Med Genet       Date:  2011-11-22       Impact factor: 2.103

Review 9.  Blood markers of oxidative stress in Alzheimer's disease.

Authors:  Alice Skoumalová; Jakub Hort
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

Review 10.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.